Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion type Assertion NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_head.
- NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion description "[Furthermore, in the presence of ALDH2*1/2*2, the risks for multiple intra-esophageal cancers (OR = 3.43) and for esophageal cancer with oropharyngolaryngeal and/or stomach cancer (OR = 3.95) were higher than the risks for solitary intra-esophageal cancer and for esophageal cancer alone, but these tendencies were not observed for ADH2*1/2*1 genotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_provenance.
- NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion evidence source_evidence_literature NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_provenance.
- NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion SIO_000772 11238183 NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_provenance.
- NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion wasDerivedFrom gad-20150221 NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_provenance.
- NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_assertion wasGeneratedBy ECO_0000203 NP69356.RAHbVJVjNnXyJEiGkEzG37j8RKmlF0Z9-NJ22lB2VnFZ0130_provenance.